Cargando…

Long lasting hypercoagulability after subclinical COVID-19

Detalles Bibliográficos
Autores principales:	Ferroli, Paolo, Villa, Chiara, Ciuffi, Andrea, Gubertini, Guido, Broggi, Morgan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405789/ https://www.ncbi.nlm.nih.gov/pubmed/32757154 http://dx.doi.org/10.1007/s11239-020-02215-3

Ejemplares similares

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Cerruti, Lorenzo, et al.
Publicado: (2020)

How to compare outcomes and complications in neurosurgery: We must make the mission possible!
por: Broggi, Morgan, et al.
Publicado: (2018)

Long-Lasting Cognitive Abnormalities after COVID-19
por: Ferrucci, Roberta, et al.
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021)

More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia
por: Spiezia, Luca, et al.
Publicado: (2020)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022)

Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
por: Zhang, Shuoqi, et al.
Publicado: (2021)

COVID-19-Induced Hypercoagulability: A Case Report
por: Sperry, Bailey, et al.
Publicado: (2022)

Re: Late diagnosis of COVID-19 and hypercoagulable state
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Response to late diagnosis of COVID-19 and hypercoagulable state
por: Desdiani, Desdiani
Publicado: (2022)

WITHDRAWN: More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared to Other Oneumonia
por: Spiezia, Luca, et al.
Publicado: (2021)

Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state
por: Insausti-García, Alfredo, et al.
Publicado: (2020)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
por: Goshua, George, et al.
Publicado: (2021)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

Hypercoagulability in COVID-19: from an unknown beginning to future therapies
por: Duca, Ştefania-Teodora, et al.
Publicado: (2022)

Subclinical myopathic changes in COVID-19
por: Villa, Davide, et al.
Publicado: (2021)

Hypercoagulability in Dogs with Blastomycosis
por: McMichael, M.A., et al.
Publicado: (2015)

Two alternative dural sealing techniques in posterior fossa surgery: (Polylactide-co-glycolide) self-adhesive resorbable membrane versus polyethylene glycol hydrogel
por: Schiariti, Marco, et al.
Publicado: (2014)

Subclinical myopathic changes in COVID-19
por: Villa, Davide, et al.
Publicado: (2021)

Emerging patterns of hypercoagulability associated with critical COVID-19: A review
por: Frazer, John Scott, et al.
Publicado: (2020)

Hypercoagulability and Anticoagulation in Patients With COVID-19 Requiring Renal Replacement Therapy
por: Roberts, Lara N., et al.
Publicado: (2020)

Hypercoagulable State in COVID-19: A Case Series of Three Patients
por: Logan, Gideon, et al.
Publicado: (2020)

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
por: Bautista-Vargas, Mario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g43nv139e6el6ocl5feqsmhvld